|
POMDOCTOR LIMITED
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
December 31, 2024
|
|
|
June 30, 2025
|
|
|
June 30, 2025
|
|
|
|
RMB
|
|
|
RMB
|
|
|
US$
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents (including amounts of the consolidated VIEs of RMB7,596,708 and RMB5,579,802 (US$778,910) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
7,651,695
|
|
|
|
5,746,989
|
|
|
|
802,249
|
|
|
Accounts receivable, net (including amounts of the consolidated VIEs of RMB8,374,608 and RMB6,128,066 (US$855,445) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
8,374,608
|
|
|
|
6,128,066
|
|
|
|
855,445
|
|
|
Accounts receivable – a related party (including amounts of the consolidated VIEs of RMB424,259 and RMB584,802 (US$81,635) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
424,259
|
|
|
|
584,802
|
|
|
|
81,635
|
|
|
Amount due from related parties (including amounts of the consolidated VIEs of RMB6,070,945 and RMB9,643,039 (US$1,346,117) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
5,632,987
|
|
|
|
7,418,671
|
|
|
|
1,035,607
|
|
|
Inventories (including amounts of the consolidated VIEs of RMB9,165,973 and RMB6,447,637 (US$900,055) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
9,165,973
|
|
|
|
6,447,637
|
|
|
|
900,055
|
|
|
Other receivables, net (including amounts of the consolidated VIEs of RMB5,318,724 and RMB5,231,722 (US$730,319) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
5,318,724
|
|
|
|
5,231,722
|
|
|
|
730,319
|
|
|
Advances to suppliers (including amounts of the consolidated VIEs of RMB929,167 and RMB2,921,966 (US$407,891) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
929,167
|
|
|
|
2,921,966
|
|
|
|
407,891
|
|
|
Total current assets
|
|
|
37,497,413
|
|
|
|
34,479,853
|
|
|
|
4,813,201
|
|
|
Non-current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net (including amounts of the consolidated VIEs of RMB461,362 and RMB394,107 (US$55,015) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
461,362
|
|
|
|
394,107
|
|
|
|
55,015
|
|
|
Other non-current assets (including amounts of the consolidated VIEs of RMB831,132 and RMB1,307,832 (US$182,566) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
831,132
|
|
|
|
1,307,832
|
|
|
|
182,566
|
|
|
Deferred offering costs (including amounts of the consolidated VIEs of RMB7,437,679 and RMB6,007,339 (US$838,592) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
7,437,679
|
|
|
|
7,690,157
|
|
|
|
1,073,505
|
|
|
Total non-current assets
|
|
|
8,730,173
|
|
|
|
9,392,096
|
|
|
|
1,311,086
|
|
|
Total assets
|
|
|
46,227,586
|
|
|
|
43,871,949
|
|
|
|
6,124,287
|
|
|
|
|
POMDOCTOR LIMITED
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS — (Continued)
|
|
|
|
|
|
December 31, 2024
|
|
|
June 30, 2025
|
|
|
June 30, 2025
|
|
|
|
RMB
|
|
|
RMB
|
|
|
US$
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
Accounts payable (including amounts of the consolidated VIEs of RMB25,320,486 and RMB25,164,804 (US$3,512,871) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
25,320,486
|
|
|
|
25,164,804
|
|
|
|
3,512,871
|
|
|
Accounts payable – a related party (including amounts of the consolidated VIEs of RMB25,891 and RMB13,711 (US$1,914) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
25,891
|
|
|
|
13,711
|
|
|
|
1,914
|
|
|
Short-term bank loans (including amounts of the consolidated VIEs of RMB34,958,333 and RMB34,708,333 (US$4,845,096) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
34,958,333
|
|
|
|
34,708,333
|
|
|
|
4,845,096
|
|
|
Long-term bank loans, current (including amounts of the consolidated VIEs of RMB300,000 and RMB2,400,000 (US$335,027) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
300,000
|
|
|
|
2,400,000
|
|
|
|
335,027
|
|
|
Long-term loans, current (including amounts of the consolidated VIEs of RMB10,000,000 and RMB10,000,000 (US$1,395,946) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
10,000,000
|
|
|
|
10,000,000
|
|
|
|
1,395,946
|
|
|
Long-term loans from third parties, current (including amounts of the consolidated VIEs of RMB2,320,082 and RMB2,295,082 (US$320,381) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
2,320,082
|
|
|
|
2,295,082
|
|
|
|
320,381
|
|
|
Salary and welfare payable (including amounts of the consolidated VIEs of RMB15,375,537 and RMB15,543,259 (US$2,169,755) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
15,375,537
|
|
|
|
15,543,259
|
|
|
|
2,169,755
|
|
|
Advance from customers (including amounts of the consolidated VIEs of RMB1,756,046 and RMB942,724 (US$131,599) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
1,756,046
|
|
|
|
942,724
|
|
|
|
131,599
|
|
|
Value added tax (“VAT”) and other tax payable (including amounts of the consolidated VIEs of RMB815,462 and RMB998,295 (US$139,357) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
815,462
|
|
|
|
998,295
|
|
|
|
139,357
|
|
|
Other payables (including amounts of the consolidated VIEs of RMB12,888,550 and RMB10,543,238 (US$1,471,777) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
12,888,750
|
|
|
|
10,543,438
|
|
|
|
1,471,806
|
|
|
Accrued liabilities (including amounts of the consolidated VIEs of RMB9,712,966 and RMB11,564,144 (US$1,614,292) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
9,712,966
|
|
|
|
11,564,144
|
|
|
|
1,614,292
|
|
|
Short-term loans from third parties (including amounts of the consolidated VIEs of RMB11,551,614 and RMB7,194,342 (US$1,004,291) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
11,551,614
|
|
|
|
7,194,342
|
|
|
|
1,004,291
|
|
|
Loans from related parties, current (including amounts of the consolidated VIEs of RMB13,821,875 and RMB33,194,670 (US$4,633,797) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
13,821,875
|
|
|
|
33,194,670
|
|
|
|
4,633,797
|
|
|
Amount due to related parties (including amounts of the consolidated VIEs of RMB36,829,010 and RMB42,403,073 (US$5,919,241) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
36,829,010
|
|
|
|
42,403,073
|
|
|
|
5,919,241
|
|
|
|
|
POMDOCTOR LIMITED
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS — (Continued)
|
|
|
|
|
|
December 31, 2024
|
|
|
June 30, 2025
|
|
|
June 30, 2025
|
|
|
|
RMB
|
|
|
RMB
|
|
|
US$
|
|
|
Operating lease liabilities, current (including amounts of the consolidated VIEs of RMB1,388,863 and RMB1,790,319 (US$249,919) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
1,388,863
|
|
|
|
1,790,319
|
|
|
|
249,919
|
|
|
Other current liabilities (including amounts of the consolidated VIEs of RMB2,080,556 and RMB237,580 (US$33,165) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
2,080,556
|
|
|
|
237,580
|
|
|
|
33,165
|
|
|
Total current liabilities
|
|
|
179,145,471
|
|
|
|
198,993,774
|
|
|
|
27,778,457
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term bank loans, noncurrent (including amounts of the consolidated VIEs of RMB8,400,000 and RMB5,700,000 (US$795,689) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
8,400,000
|
|
|
|
5,700,000
|
|
|
|
795,689
|
|
|
Loans from related parties, noncurrent (including amounts of the consolidated VIEs of RMB356,690,859 and RMB356,390,859 (US$49,750,246) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
356,690,859
|
|
|
|
356,390,859
|
|
|
|
49,750,246
|
|
|
Operating lease liabilities, noncurrent (including amounts of the consolidated VIEs of RMB1,672,218 and RMB2,346,664 (US$327,582) as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
1,672,218
|
|
|
|
2,346,664
|
|
|
|
327,582
|
|
|
Total non-current liabilities
|
|
|
366,763,077
|
|
|
|
364,437,523
|
|
|
|
50,873,517
|
|
|
Total liabilities
|
|
|
545,908,548
|
|
|
|
563,431,297
|
|
|
|
78,651,974
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible redeemable preferred shares (US$0.0001 par value; 12,597,228 shares authorized, issued and outstanding as of December 31, 2024 and June 30, 2025)
|
|
|
1,595,051,558
|
|
|
|
1,642,498,390
|
|
|
|
229,283,934
|
|
|
Redeemable non-controlling interests
|
|
|
168,671,234
|
|
|
|
173,630,137
|
|
|
|
24,237,833
|
|
|
Total mezzanine equity
|
|
|
1,763,722,792
|
|
|
|
1,816,128,527
|
|
|
|
253,521,767
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity (deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A ordinary shares (US$0.0001 par value; 485,360,730 shares authorized, 4,268,156 shares issued and outstanding as of December 31, 2024 and June 30, 2025)
|
|
|
2,988
|
|
|
|
2,988
|
|
|
|
417
|
|
|
Class B Ordinary shares (US$0.0001 par value; 2,042,042 shares authorized and outstanding as of December 31, 2024 and June 30, 2025, respectively)
|
|
|
1,408
|
|
|
|
1,408
|
|
|
|
197
|
|
|
Subscription receivable
|
|
|
(1,608)
|
|
|
|
(1,608)
|
|
|
|
(224)
|
|
|
Accumulated deficit
|
|
|
(2,263,419,477)
|
|
|
|
(2,335,709,744)
|
|
|
|
(326,052,508)
|
|
|
Accumulated other comprehensive (loss) income
|
|
|
(5,231)
|
|
|
|
1,875
|
|
|
|
262
|
|
|
Total Pomdoctor Limited’s shareholders’ deficit
|
|
|
(2,263,421,920)
|
|
|
|
(2,335,705,081)
|
|
|
|
(326,051,856)
|
|
|
Noncontrolling interests
|
|
|
18,166
|
|
|
|
17,206
|
|
|
|
2,402
|
|
|
Total deficit
|
|
|
(2,263,403,754)
|
|
|
|
(2,335,687,875)
|
|
|
|
(326,049,454)
|
|
|
Total liabilities, mezzanine equity and deficit
|
|
|
46,227,586
|
|
|
|
43,871,949
|
|
|
|
6,124,287
|
|